AstraZeneca Stock: Waiting For A Better Price (NASDAQ:AZN)
jetcityimage/iStock Editorial via Getty Images AstraZeneca (NASDAQ:AZN) is a powerhouse of pharmaceutical development with strong oncology, rare diseases, and biopharmaceutical segments. They grow organically but have also engaged in acquisitions, such as the $39 billion […]
